Verge Genomics
Leadership Approach Pipeline Partnerships News Careers
LeadershipApproachPipelinePartnershipsNewsCareers
Verge Genomics

Verge Genomics at ALS Gordon Research Conference in Switzerland

At Next week’s ALS Gordon Research Conference in Switzerland, Irene Choi will share insights on PIKfyve, a potential therapeutic target for ALS discovered using Verge's all-in-human, AI-powered CONVERGE™ platform. Check out the full agenda here: https://tinyurl.com/2y62s5nd

EventsRob MaguireJune 30, 2023
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

CMO Diego Cadavid, M.D. to present data for Phase 1 of VRG50635 at ENCALS 2023

EventsRob MaguireJuly 13, 2023
Next

Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

Press ReleaseRob MaguireJune 15, 2023
  • Home
  • Leadership
  • Approach
  • Pipeline
  • Accessibility
  • Partnerships
  • News
  • Careers
  • Privacy
Verge Genomics Logo

131 Oyster Point Blvd
Suite 300
South San Francisco
CA 94080

  • LinkedIn icon graphic
    X logo icon graphic
  • info@vergegenomics.com
Copyright 2023